Chemical affinity and dispersibility of boron nitride nanotubes.

Boron nitride nanotubes (BNNTs) are electrically insulating nanoparticles that display highly competitive elastic modulus and thermal conductivity. Long presented as potential fillers for nanocomposite applications, their poor dispersibility in most commodity polymers has, however, limited their spread. In this work, the chemical affinity of purified BNNTs, measured in terms of Hansen solubility parameters (HSP), were obtained through sedimentation tests in a wide set of organic solvents, taking into account relative sedimentation time. The parameters obtained were {δ d; δ p; δ h} = {16.8; 10.7; 14.7} ± {0.3; 0.9; 0.3} MPa1/2, with a Hildebrand parameter, δ t = 24.7 MPa1/2 and a sphere radius of 5.4 MPa1/2. The solubility parameters were determined considering complete dispersion of the purified nanomaterial, as well as the viscosity and density of the host solvent. These factors, combined with the high purity of the BNNTs, are crucial to minimize the uncertainty of the HSP characterization. Such refined values provide necessary insights both to optimize the solvent casting of unmodified BNNTs, and to orient the surface modification efforts that would be needed to integrate these nanomaterials into a wider range of host matrices.

M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts.

BACKGROUND: The nasopharynx is a known gateway for some mycobacterial species such as Mycobacterium bovis and M. leprae. M. tuberculosis can cross lymphoepithelial barriers in vitro, but its ability to colonise the nasopharyngeal mucosa in vivo has not been established. OBJECTIVE: To determine if M. tuberculosis can be transiently detected in nasopharyngeal mucosa of tuberculosis (TB) contacts as a preliminary step in the development of tuberculous infection. DESIGN: Exploratory study conducted among asymptomatic household contacts of pulmonary TB cases. A chest X-ray, QuantiFERON(®) TB-Gold or tuberculin skin test and a bilateral nasopharyngeal swab for Xpert(®) MTB/RIF and mycobacterial culture were performed at baseline and repeated 8-12 weeks later. RESULTS: Eighty-nine contacts were enrolled a median of 9 days after the diagnosis of the index case. At baseline, 29.9% were positive for latent tuberculous infection and one subject (1.1%) had a positive Xpert in the nasopharyngeal swab with a normal chest X-ray, negative QuantiFERON and negative induced sputum. After 12 weeks' follow-up, this subject developed a new cough and upper lobe infiltrates and M. tuberculosis grew in sputum. No other cases of active TB were detected at follow-up. CONCLUSION: The detection of M. tuberculosis DNA in the nasopharyngeal mucosa of contacts is an infrequent event that in this instance preceded the development of pulmonary TB. Its pathogenic role requires further investigation.